Original Research

Published on 04 Jan 2022

TMEM88 Modulates Lipid Synthesis and Metabolism Cytokine by Regulating Wnt/β-Catenin Signaling Pathway in Non-Alcoholic Fatty Liver Disease

in Gastrointestinal and Hepatic Pharmacology

Huan Zhou
Xingyu Zhu
Yan Yao
Yue Su
Jing Xie
Minhui Zhu
Cuixia He
Jiaxiang Ding
Yuanyuan Xu
Rongfang Shan

Frontiers in Pharmacology

doi 10.3389/fphar.2021.798735

4,312 views
4 citations

Review

Published on 03 Jan 2022

Production of Bovine Colostrum for Human Consumption to Improve Health

in Gastrointestinal and Hepatic Pharmacology

Merve Kaplan
Ayşenur Arslan
Hatice Duman
Melda Karyelioğlu
Barış Baydemir
Bilgetekin Burak Günar
Merve Alkan
Ayşe Bayraktar
Halil İbrahim Tosun
Melih Ertürk

Frontiers in Pharmacology

doi 10.3389/fphar.2021.796824

76,354 views
25 citations

Original Research

Published on 03 Jan 2022

Clinical and Immunological Factors Associated with Recommended Trough Levels of Adalimumab and Infliximab in Patients with Crohn’s Disease

in Gastrointestinal and Hepatic Pharmacology

Beatriz Orts
Ana Gutierrez
Lucía Madero
Laura Sempere
Ruben Frances
Pedro Zapater

Frontiers in Pharmacology

doi 10.3389/fphar.2021.795272

2,512 views
2 citations

Original Research

Published on 03 Jan 2022

Vagus Nerve Stimulation Attenuates Acute Skeletal Muscle Injury Induced by Hepatic Ischemia/Reperfusion Injury in Rats

in Gastrointestinal and Hepatic Pharmacology

Ying Xin
Yifeng Zhang
Simin Deng
Xinqun Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.756997

2,701 views
7 citations

Original Research

Published on 24 Dec 2021

SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy

in Gastrointestinal and Hepatic Pharmacology

Elena De Mattia
Vincenzo Canzonieri
Jerry Polesel
Silvia Mezzalira
Chiara Dalle Fratte
Eva Dreussi
Rossana Roncato
Alessia Bignucolo
Roberto Innocente
Claudio Belluco

Frontiers in Pharmacology

doi 10.3389/fphar.2021.778781

2,842 views
4 citations

Review

Published on 23 Dec 2021

Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment

in Gastrointestinal and Hepatic Pharmacology

Oana-Maria Thoma
Markus F. Neurath
Maximilian J. Waldner

Frontiers in Pharmacology

doi 10.3389/fphar.2021.757120

10,424 views
41 citations

Review

Published on 23 Dec 2021

Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases

in Gastrointestinal and Hepatic Pharmacology

Vishakha Singh
Amit Khurana
Prince Allawadhi
Anil Kumar Banothu
Kala Kumar Bharani
Ralf Weiskirchen

Frontiers in Pharmacology

doi 10.3389/fphar.2021.790963

8,163 views
21 citations

Original Research

Published on 23 Dec 2021

Total Flavone of Abelmoschus manihot Ameliorates TNBS-Induced Colonic Fibrosis by Regulating Th17/Treg Balance and Reducing Extracellular Matrix

in Gastrointestinal and Hepatic Pharmacology

Lichao Qiao
Lei Fang
Junyi Zhu
Yu Xiang
Haixia Xu
Xueliang Sun
Hongjin Chen
Bolin Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.769793

3,769 views
12 citations

Review

Published on 21 Dec 2021

Targeting Mechano-Transcription Process as Therapeutic Intervention in Gastrointestinal Disorders

in Gastrointestinal and Hepatic Pharmacology

Ramasatyaveni Geesala
You-Min Lin
Ke Zhang
Xuan-Zheng Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2021.809350

4,710 views
11 citations

Original Research

Published on 21 Dec 2021

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease

in Gastrointestinal and Hepatic Pharmacology

Yuting Ma
Chengxia Kan
Hongyan Qiu
Yongping Liu
Ningning Hou
Fang Han
Junfeng Shi
Xiaodong Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2021.793586

5,048 views
14 citations

Original Research

Published on 21 Dec 2021

Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling

in Gastrointestinal and Hepatic Pharmacology

Yun Li
Huiqin Hou
Xianglu Wang
Xin Dai
Wanru Zhang
Qiang Tang
Yue Dong
Chen Yan
Bangmao Wang
Zhengxiang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.796590

6,879 views
20 citations

Review

Published on 21 Dec 2021

An Update on the Effects of Probiotics on Gastrointestinal Cancers

in Gastrointestinal and Hepatic Pharmacology

Amirhossein Davoodvandi
Farzaneh Fallahi
Omid Reza Tamtaji
Vida Tajiknia
Zarrin Banikazemi
Hadis Fathizadeh
Mohammad Abbasi-Kolli
Michael Aschner
Maryam Ghandali
Amirhossein Sahebkar

Frontiers in Pharmacology

doi 10.3389/fphar.2021.680400

14,846 views
16 citations

Original Research

Published on 20 Dec 2021

Resolvin D1 attenuates CCl4 Induced Liver Fibrosis by Inhibiting Autophagy-Mediated HSC activation via AKT/mTOR Pathway

in Gastrointestinal and Hepatic Pharmacology

Jiahuan Li
Xiaoling Deng
Shuhan Wang
Qianqian Jiang
Keshu Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.792414

7,192 views
24 citations

Systematic Review

Published on 20 Dec 2021

Understanding the Role of Purinergic P2X7 Receptors in the Gastrointestinal System: A Systematic Review

in Gastrointestinal and Hepatic Pharmacology

Nathalie Cheng
Li Zhang
Lu Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.786579

3,968 views
13 citations

Original Research

Published on 16 Dec 2021

Epidemiology, Clinical Features, and Prescribing Patterns of Irritable Bowel Syndrome in Taiwan

in Gastrointestinal and Hepatic Pharmacology

Yu-Tung Lai
Chung-Yu Chen
Ming-Jong Bair

Frontiers in Pharmacology

doi 10.3389/fphar.2021.788795

7,083 views
10 citations

Original Research

Published on 16 Dec 2021

Age-Related Decrease in Abdominal Pain and Associated Structural- and Functional Mechanisms: An Exploratory Study in Healthy Individuals and Irritable Bowel Syndrome Patients

in Gastrointestinal and Hepatic Pharmacology

Abraham B. Beckers
Ellen Wilms
Zlatan Mujagic
Béla Kajtár
Kata Csekő
Zsa Zsa R. M. Weerts
Lisa Vork
Freddy J. Troost
Joanna W. Kruimel
José M. Conchillo

Frontiers in Pharmacology

doi 10.3389/fphar.2021.806002

3,761 views
13 citations

Navigation group

Articles

TMEM88 Modulates Lipid Synthesis and Metabolism Cytokine by Regulating Wnt/β-Catenin Signaling Pathway in Non-Alcoholic Fatty Liver Disease

Production of Bovine Colostrum for Human Consumption to Improve Health

Clinical and Immunological Factors Associated with Recommended Trough Levels of Adalimumab and Infliximab in Patients with Crohn’s Disease

Vagus Nerve Stimulation Attenuates Acute Skeletal Muscle Injury Induced by Hepatic Ischemia/Reperfusion Injury in Rats

SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy

Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment

Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases

Total Flavone of Abelmoschus manihot Ameliorates TNBS-Induced Colonic Fibrosis by Regulating Th17/Treg Balance and Reducing Extracellular Matrix

Targeting Mechano-Transcription Process as Therapeutic Intervention in Gastrointestinal Disorders

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease

Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling

An Update on the Effects of Probiotics on Gastrointestinal Cancers

Resolvin D1 attenuates CCl4 Induced Liver Fibrosis by Inhibiting Autophagy-Mediated HSC activation via AKT/mTOR Pathway

Understanding the Role of Purinergic P2X7 Receptors in the Gastrointestinal System: A Systematic Review

Epidemiology, Clinical Features, and Prescribing Patterns of Irritable Bowel Syndrome in Taiwan

Age-Related Decrease in Abdominal Pain and Associated Structural- and Functional Mechanisms: An Exploratory Study in Healthy Individuals and Irritable Bowel Syndrome Patients